Rebalix
UBS · sheet of 10 September 2026
UBS · sheet of 10 September 2026ETF sheet · official issuer and register data
UBS BBG USD EM Sovereign UCITS ETF hGBP dis
LU1324516480 · LU1324516480 · GBP · domicile Luxembourg
Bonds · Government USD · Broad (all maturities) · Emerging marketsGBP-hedged share classSFDR art. 6
Index tracked: Bloomberg Emerging Markets USD Sovereign & Agency 3% Country Capped Index hedged to GBP
- TER
- 0.28%+ trans. 0.06%
- Fund size
- —
- Tracking difference
- −0.33%3-year avg
- 🇮🇹 tax rate
- 18.49%white list 55.60%
- Replication
- Physical (mixed: optimised/sampled)
- Income
- Distributingsemi-annual
- Duration
- 6.19 yrsmedium (3–7 years)
Launch 29 Apr 2016 · costs from the KID as of 26 Aug 2026
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 2 Sept 2026
Il Fondo è gestito in modo passivo e assumerà un'esposizione proporzionale alle componenti del Bloomberg Emerging Markets USD Sovereign & Agency 3% Country Capped Index (Total Return) attraverso un approccio stratificato (strategia di campionamento stratificato) che prevede l'investimento in un campione rappresentativo di titoli che compongono l'indice selezionati dal gestore di portafoglio mediante una tecnica di «ottimizzazione del portafoglio». L'esposizione proporzionale del Fondo alle componenti dell'indice sarà in gran parte ottenuta con…
Performance since series start (in euro) — base 100
29 Apr 2016 → 8 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +8.2% |
| 3 years | +34.8% |
| 5 years | +6.9% |
| 10 years | +19.6% |
| Since series start | +19.8% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 5.83% | 7.47% | 8.23% |
| Max drawdown | −6.11% | −10.69% | −35.55% |
| Sharpe | -0.34 | -0.05 | -0.96 |
| Sortino | -0.40 | -0.05 | -1.15 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · LU1324516480 · LU13245164801
RebalixLU1324516480 · LU1324516480 · sheet of 10 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · fund with dividends reinvested by Rebalix on each ex-date (no issuer total-return series); index from the declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +14.74% | +15.00% | −0.26% |
| 2024 | +7.37% | +7.62% | −0.25% |
| 2023 | +10.37% | +10.84% | −0.47% |
| 2022 | −20.61% | −20.89% | +0.28% |
| 2021 | −3.11% | −2.54% | −0.57% |
Fixed income — as declared by the issuer
Factsheet · 31 Jul 2026
Distributions · per share, in GBP
Frequency: semi-annual · last 12 months: 0.541 GBP (6.64% of NAV) · last ex-date 13 Aug 2026
| Year | Payments | Total (GBP) | Dividend yield |
|---|---|---|---|
| 2026 | 2 | 0.541 | — |
| 2025 | 2 | 0.8155 | +9.96% |
| 2024 | 2 | 0.483 | +5.96% |
| 2023 | 2 | 0.4998 | +6.39% |
| 2022 | 2 | 0.5015 | +4.81% |
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.
Listing venues
ESMA register (FIRDS) and official exchange lists
No EU listing in the ESMA register.
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/LU1324516480
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/LU1324516480
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · LU1324516480 · LU13245164802